KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Debt to Equity (2016 - 2025)

Historic Debt to Equity for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $0.04.

  • Resmed's Debt to Equity rose 208046.26% to $0.04 in Q4 2025 from the same period last year, while for Dec 2025 it was $0.04, marking a year-over-year increase of 208046.26%. This contributed to the annual value of $0.0 for FY2025, which is 1849.6% down from last year.
  • Latest data reveals that Resmed reported Debt to Equity of $0.04 as of Q4 2025, which was up 208046.26% from $0.04 recorded in Q3 2025.
  • Resmed's Debt to Equity's 5-year high stood at $0.04 during Q3 2025, with a 5-year trough of $0.0 in Q2 2025.
  • Over the past 5 years, Resmed's median Debt to Equity value was $0.0 (recorded in 2022), while the average stood at $0.01.
  • Per our database at Business Quant, Resmed's Debt to Equity crashed by 3101.74% in 2023 and then skyrocketed by 212890.49% in 2025.
  • Quarter analysis of 5 years shows Resmed's Debt to Equity stood at $0.0 in 2021, then plummeted by 30.57% to $0.0 in 2022, then dropped by 16.61% to $0.0 in 2023, then decreased by 14.61% to $0.0 in 2024, then surged by 2080.46% to $0.04 in 2025.
  • Its Debt to Equity stands at $0.04 for Q4 2025, versus $0.04 for Q3 2025 and $0.0 for Q2 2025.